XML 70 R60.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Commitments and Contingencies (Details)
$ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended
Feb. 23, 2023
USD ($)
Jan. 31, 2022
USD ($)
Jan. 31, 2022
USD ($)
Device
Jun. 30, 2024
USD ($)
Jun. 30, 2023
USD ($)
Jun. 30, 2024
USD ($)
Jun. 30, 2023
USD ($)
Lessee, Operating Lease, Description [Abstract]              
Extended lease term       5 years   5 years  
Increase in ROU asset and operating lease liability resulting from lease modification       $ 977     $ 0
Operating lease costs       122 $ 123 $ 228 229
Cash paid for amounts included in measurement of operating lease liabilities       $ 112 109 $ 224 205
Weighted average incremental borrowing rate           12.01%  
Weighted average remaining lease term       4 years 6 months   4 years 6 months  
Operating Lease Maturities [Abstract]              
Remaining 2024       $ 229   $ 229  
2025       463   463  
2026       334   334  
2027       290   290  
2028       301   301  
Thereafter       231   231  
Total remaining lease payments       1,848   1,848  
Less: imputed interest       (452)   (452)  
Total lease liabilities       1,396   $ 1,396  
Milestone Payments [Abstract]              
Development agreement term           3 years  
Litigation Settlement [Abstract]              
Litigation settlement to be paid $ 106            
Litigation settlement accrued       $ 106 $ 106 $ 106 $ 106
TheraClear Corporation [Member]              
Milestone Payments [Abstract]              
Future earnout payment due upon revenue target   $ 1,000 $ 1,000        
Royalty and gross profit payments incurred           87  
TheraClear Corporation [Member] | Foreign [Member]              
Milestone Payments [Abstract]              
Percentage of gross profit for future royalty payments for subsequent period   25.00%          
Subsequent period of gross profit for future royalty payments       4 years      
Tax Period from March 2014 through November 2022 [Member]              
Sales and Use Tax Matters [Abstract]              
Estimated tax positions subject to audit           4,879  
Tax Period from March 2014 through November 2022 [Member] | Assessment One [Member]              
Sales and Use Tax Matters [Abstract]              
Assessment amount       $ 1,484   1,484  
Tax Period from March 2014 through November 2022 [Member] | Assessment Two [Member]              
Sales and Use Tax Matters [Abstract]              
Assessment amount       $ 1,273   1,273  
Tax Period From June 2018 Through June 2022 [Member]              
Sales and Use Tax Matters [Abstract]              
Estimated tax positions subject to audit           $ 2,122  
Minimum [Member]              
Lessee, Operating Lease, Description [Abstract]              
Remaining lease term           1 year  
Minimum [Member] | TheraClear Corporation [Member] | Domestic [Member]              
Milestone Payments [Abstract]              
Percentage of gross profit for future royalty payments for subsequent period   10.00%          
Maximum [Member]              
Lessee, Operating Lease, Description [Abstract]              
Remaining lease term           5 years  
Milestone Payments [Abstract]              
Future earnout payments   $ 500 500        
Future milestone payments   3,000 $ 3,000        
Number of devices in development | Device     3        
Maximum [Member] | Domestic [Member]              
Milestone Payments [Abstract]              
Future royalty payments   500 $ 500        
Maximum [Member] | TheraClear Corporation [Member]              
Milestone Payments [Abstract]              
Future earnout payments   3,000 3,000        
Future milestone payments   500 500        
Maximum [Member] | TheraClear Corporation [Member] | Domestic [Member]              
Milestone Payments [Abstract]              
Future royalty payments   $ 20,000 $ 20,000        
Percentage of gross profit for future royalty payments for subsequent period   20.00%